JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4701
Farmers & Merchants Bancorp
FMAO
$489M
| $242K | ﹤0.01% |
8,889
+2,271
| +34% | +$64K |
2017 Q4
20 quarters
|
|
4702
ProShares UltraPro Dow 30
UDOW
$904M
| $242K | ﹤0.01% |
8,530
-5,658
| -40% | -$155K |
2022 Q3
1 quarter
|
|
|
SPLK
4703
CALL
DELISTED
Splunk Inc
SPLK
| $241K | ﹤0.01% |
2,800
+2,600
| +1,300% | +$210K |
2022 Q1
3 quarters
|
|
|
GHL
4704
DELISTED
Greenhill & Co., Inc.
GHL
| $241K | ﹤0.01% |
23,521
-25,642
| -52% | -$222K |
2013 Q2
38 quarters
|
|
|
IGD
4705
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$480M
| $240K | ﹤0.01% |
+44,387
| New | +$233K |
2022 Q4
0 quarters
|
|
4706
Advantage Solutions
ADV
$351M
| $239K | ﹤0.01% |
4,603
+1,324
| +40% | +$83.2K |
2020 Q1
11 quarters
|
|
4707
Xponential Fitness
XPOF
$202M
| $239K | ﹤0.01% |
10,444
+964
| +10% | +$19.9K |
2021 Q3
5 quarters
|
|
4708
Alamos Gold
AGI
$13.7B
| $238K | ﹤0.01% |
23,502
| – | – |
2019 Q3
13 quarters
|
|
4709
Axogen
AXGN
$2.13B
| $238K | ﹤0.01% |
23,912
+1,612
| +7% | +$17.9K |
2017 Q4
20 quarters
|
|
4710
Tejon Ranch
TRC
$441M
| $238K | ﹤0.01% |
12,653
+1,201
| +10% | +$21K |
2015 Q4
28 quarters
|
|
|
CTLP
4711
DELISTED
Cantaloupe
CTLP
| $237K | ﹤0.01% |
54,497
+21,929
| +67% | +$77.8K |
2020 Q4
8 quarters
|
|
4712
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$489M
| $237K | ﹤0.01% |
7,364
+7,292
| +10,128% | +$225K |
2022 Q3
1 quarter
|
|
4713
Dyne Therapeutics
DYN
$2.87B
| $237K | ﹤0.01% |
20,444
-23,332
| -53% | -$270K |
2020 Q4
8 quarters
|
|
4714
CALL
Idacorp
IDA
$7.67B
| $237K | ﹤0.01% |
2,200
| – | – |
2022 Q3
1 quarter
|
|
4715
Astronics
ATRO
$2.96B
| $236K | ﹤0.01% |
27,541
+10,818
| +65% | +$80K |
2017 Q4
20 quarters
|
|
4716
iShares MSCI Sweden ETF
EWD
$954M
| $236K | ﹤0.01% |
7,304
-26,932
| -79% | -$842K |
2020 Q3
9 quarters
|
|
4717
First Trust Technology AlphaDEX Fund
FXL
$2.93B
| $234K | ﹤0.01% |
2,551
+2,501
| +5,002% | +$231K |
2017 Q4
20 quarters
|
|
4718
NYLIM Merger Arbitrage ETF
MNA
$265M
| $234K | ﹤0.01% |
+7,384
| New | +$232K |
2022 Q4
0 quarters
|
|
4719
The RealReal
REAL
$1.15B
| $234K | ﹤0.01% |
187,086
+131,642
| +237% | +$189K |
2019 Q2
14 quarters
|
|
4720
Miller Industries
MLR
$617M
| $233K | ﹤0.01% |
8,763
+2,585
| +42% | +$66.2K |
2017 Q4
20 quarters
|
|
|
ALBO
4721
DELISTED
Albireo Pharma Inc
ALBO
| $233K | ﹤0.01% |
10,781
+1,283
| +14% | +$27.1K |
2018 Q2
18 quarters
|
|
4722
Vita Coco
COCO
$3.15B
| $232K | ﹤0.01% |
16,825
+1,252
| +8% | +$14.7K |
2021 Q4
4 quarters
|
|
|
VEV
4723
DELISTED
Vicinity Motor Corp. Common Stock
VEV
| $232K | ﹤0.01% |
30,900
-266,900
| -90% | -$273K |
2021 Q3
5 quarters
|
|
|
HT
4724
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $232K | ﹤0.01% |
27,292
+10,128
| +59% | +$90.9K |
2013 Q2
38 quarters
|
|
4725
iShares CMBS ETF
CMBS
$434M
| $231K | ﹤0.01% |
5,013
+790
| +19% | +$36.1K |
2020 Q4
8 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.